This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Pulmonary Adenomatosis, Ovine
Information about Pulmonary Adenomatosis, Ovine: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Pulmonary Adenomatosis, Ovine
Most recent studies have shown that Pulmonary Adenomatosis, Ovine shares some biological mechanisms with adenocarcinoma, adenocarcinoma-of-lung-(disorder), adenomatosis-pulmonary, bronchioloalveolar-adenocarcinoma, carcinoma, cell-transformation-neoplastic, infective-disorder, lung-diseases, lung-neoplasms, malignant-neoplasm-of-lung, malignant-neoplasms, neoplasm-metastasis, neoplasms, nose-neoplasms, pneumonia, pneumonia-progressive-interstitial-of-sheep, retroviridae-infections, sheep-diseases, tumor-virus-infections.
Among the many pathways, these few ones have gauged particular interests from scientists studying Pulmonary Adenomatosis, Ovine, and have been seen in publications frequently: Cell Differentiation, Cell Migration, Cell Proliferation, Cellular Senescence, Dna Integration, Endocytosis, Hypersensitivity, Immune Response, Localization, Membrane Fusion, Nuclear Export, Oncogenesis, Pathogenesis, Reverse Transcription, Secretion, Translation, Transport, Tropism, Viral Replication, Virulence
Quite a number of genes have been found to play important roles in Pulmonary Adenomatosis, Ovine, such as AKT1, BST2, DCTN6, HYAL2, IFI27, MAPK1, MAPK3, MST1R, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PSMD9, SCGB1A1, SFTPB, SFTPC, TMED7. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.